Assessment of the Potential for Drug–Drug Interactions Between INP104 and Gepants for Migraine Management Using a Model-based Approach

Presented at the AHS 65th Annual Scientific Meeting, June 15-18, 2023, Austin, Texas Authors: Ray S, Torphy B, Joshi S, Vann R, Downing B, Murphy M, Fonseca D, Shrewsbury S, Aurora S One sentence summary: Based on a critical evaluation of whether clinically relevant pharmacokinetic or pharmacodynamic drug–drug interactions (DDIs) can occur between INP104 and gepants […] The post Assessment of the Potential for Drug–Drug Interactions Between INP104 and Gepants for Migraine Management Using a Model-based Approach appeared first on Impel Pharmaceuticals .